COLLEGE PARK, Ga.–(BUSINESS WIRE)–Anthem Blue Cross Blue Shield, in partnership with iHeartMedia and national nonprofit Impact Fitness Foundation, recently celebrated the unveiling of a newly upgraded weight room they provided at Benjamin Banneker High School. The project expands Anthem’s commitment to whole health in the College Park community and supports long-term student wellness by investing … [Read more…]

LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today issued a Shareholder Letter on Tuesday, March 3 after the market close. STAAR’s results release can be found here: https://investors.staar.com/news-and-events/press-releases. Fellow Shareholders, This past month marked an … [Read more…]

PALO ALTO, Calif.–(BUSINESS WIRE)–#GenAI–Hippocratic AI, the global leader and pioneer in generative AI healthcare agents, today announced that it has been recognized as one of America’s Best Startup Employers 2026. This prestigious award is presented in collaboration with Statista, the world-leading statistics portal and industry ranking provider. The award list was announced on March 3rd, … [Read more…]

OVERLAND PARK, Kan.–(BUSINESS WIRE)–#AI–Netsmart and Pyramid Healthcare, Inc., one of the nation’s leading providers of behavioral health and addiction treatment services, announce an enhanced enterprise collaboration to strengthen the organization’s technology infrastructure and better support integrated behavioral healthcare across its multistate system. Through this expanded relationship, Pyramid Healthcare will modernize its enterprise-wide electronic health record … [Read more…]

Contract recognizes FloPatch’s unique potential to improve fluid management decisions and patient outcomes in sepsis care LOS ANGELES–(BUSINESS WIRE)–#flopatch–Flosonics Medical announced that its FloPatch wearable Doppler ultrasound device has received an Innovative Technology contract from Vizient®, the nation’s largest provider-driven healthcare performance improvement company. The contract was awarded following review by hospital experts serving on … [Read more…]

Key Milestone Signals Readiness for Regulated Diagnostic Deployment GLASGOW, Scotland–(BUSINESS WIRE)–Dxcover, a global leader in AI-enabled technologies, today announced that its breakthrough liquid biopsy medical device has successfully achieved CE marking under the European In Vitro Diagnostic Regulation (IVDR) (EU) 2017/746. “This validates not just a single product, but the underlying rigor of our infrastructure … [Read more…]

TOKYO–(BUSINESS WIRE)–Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Toshiaki Nagasato) today announced that morcamilast (proposed international nonproprietary name; development code: ME3183), a selective phosphodiesterase-4 (PDE4) inhibitor, has been granted orphan medicinal product designation by the European Commission (EC) for the treatment of palmoplantar pustulosis (PPP). Palmoplantar pustulosis is a chronic inflammatory … [Read more…]

RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, announced today that Mike Fedock, executive vice president and chief financial officer, will speak at the Barclays 28th Annual Global Healthcare Conference on Thursday, March 12, … [Read more…]

2025 Total Revenue of $233.8 million, up 16% from 2024; 2025 Product Revenue of $206.1 million, up 14% from 2024 Strengthened Financial Foundation Through Strong Commercial Execution and Disciplined Operational Management CONCORD, Calif.–(BUSINESS WIRE)–Cerus Corporation (Nasdaq: CERS) announced today financial results for its full year and fourth quarter ended December 31, 2025. “Our strong 2025 … [Read more…]

eyonis® LCS commercial launch is ongoing in U.S. following FDA 510(k) clearance CE-marking regulatory process is on-going with a decision expected in Q2 2026 that could trigger commercial rollout of eyonis® LCS across Europe this year Median eyonis® team will be at Booth #AI-16, AI Exhibition, Expo X1, to highlight clinical impact of eyonis® LCS … [Read more…]